Tirbanibulin
Back to searchMolecule Structure
Scientific Name
Tirbanibulin
Description of the Drug
Tirbanibulin is a tyrosine kinase and tubulin inhibitor used to treat actinic keratosis on the face or scalp.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06137
http://www.drugbank.ca/drugs/DB06137
Brand Name(s)
Klisyri
Company Owner(s)
Almirall Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Tyrosine-protein kinase SRC | SINGLE PROTEIN | INHIBITOR | CHEMBL267 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL153779 |
| Human Metabolome Database | HMDB0304857 |
| DrugBank | DB06137 |
| PubChem: Thomson Pharma | 46498254 |
| PubChem | 23635314 |
| LINCS | LSM-45890 |
| PDBe | DN0 |
| BindingDB | 50303801 |
| EPA CompTox Dashboard | DTXSID30237862 |
| DrugCentral | 5431 |
| ChemicalBook | CB02561484 |
| Guide to Pharmacology | 7957 |
| ZINC | ZINC000043152787 |
